Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exercise endurance study of dual bronchodilator GSK573719/GW642444 in COPD
2010-023442-75Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Anoro Ellipta in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by GSK. Primary endpoint: Exercise endurance time post-dose at Week 12. Started Mar 2011; status: completed.
02
Drugs
Anoro Ellipta
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2010-023442-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023442-75.